Revvity Goodwill and Intangible Assets 2010-2025 | RVTY
Revvity goodwill and intangible assets from 2010 to 2025. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
- Revvity goodwill and intangible assets for the quarter ending June 30, 2025 were $9.129B, a 2.07% decline year-over-year.
- Revvity goodwill and intangible assets for 2024 were $9.105B, a 4.72% decline from 2023.
- Revvity goodwill and intangible assets for 2023 were $9.556B, a 3.07% decline from 2022.
- Revvity goodwill and intangible assets for 2022 were $9.859B, a 5.65% decline from 2021.
| Revvity Annual Goodwill and Intangible Assets (Millions of US $) |
|
|---|---|
| 2024 | $9,105 |
| 2023 | $9,556 |
| 2022 | $9,859 |
| 2021 | $10,449 |
| 2020 | $4,813 |
| 2019 | $4,395 |
| 2018 | $4,152 |
| 2017 | $4,349 |
| 2016 | $2,668 |
| 2015 | $2,723 |
| 2014 | $2,774 |
| 2013 | $2,604 |
| 2012 | $2,653 |
| 2011 | $2,756 |
| 2010 | $1,929 |
| 2009 | $1,862 |
| Revvity Quarterly Goodwill and Intangible Assets (Millions of US $) |
|
|---|---|
| 2025-06-30 | $9,129 |
| 2025-03-31 | $9,083 |
| 2024-12-31 | $9,105 |
| 2024-09-30 | $9,322 |
| 2024-06-30 | $9,322 |
| 2024-03-31 | $9,423 |
| 2023-12-31 | $9,556 |
| 2023-09-30 | $9,555 |
| 2023-06-30 | $9,716 |
| 2023-03-31 | $9,801 |
| 2022-12-31 | $9,859 |
| 2022-09-30 | $9,774 |
| 2022-06-30 | $11,015 |
| 2022-03-31 | $11,310 |
| 2021-12-31 | $10,449 |
| 2021-09-30 | $11,581 |
| 2021-06-30 | $5,406 |
| 2021-03-31 | $5,157 |
| 2020-12-31 | $4,813 |
| 2020-09-30 | $4,344 |
| 2020-06-30 | $4,296 |
| 2020-03-31 | $4,252 |
| 2019-12-31 | $4,395 |
| 2019-09-30 | $4,187 |
| 2019-06-30 | $4,324 |
| 2019-03-31 | $4,107 |
| 2018-12-31 | $4,152 |
| 2018-09-30 | $4,144 |
| 2018-06-30 | $4,212 |
| 2018-03-31 | $4,332 |
| 2017-12-31 | $4,349 |
| 2017-09-30 | $2,814 |
| 2017-06-30 | $2,810 |
| 2017-03-31 | $2,788 |
| 2016-12-31 | $2,668 |
| 2016-09-30 | $2,766 |
| 2016-06-30 | $2,727 |
| 2016-03-31 | $2,778 |
| 2015-12-31 | $2,723 |
| 2015-09-30 | $2,678 |
| 2015-06-30 | $2,730 |
| 2015-03-31 | $2,723 |
| 2014-12-31 | $2,774 |
| 2014-09-30 | $2,520 |
| 2014-06-30 | $2,559 |
| 2014-03-31 | $2,580 |
| 2013-12-31 | $2,604 |
| 2013-09-30 | $2,612 |
| 2013-06-30 | $2,604 |
| 2013-03-31 | $2,618 |
| 2012-12-31 | $2,653 |
| 2012-09-30 | $2,698 |
| 2012-06-30 | $2,693 |
| 2012-03-31 | $2,742 |
| 2011-12-31 | $2,756 |
| 2011-09-30 | $2,271 |
| 2011-06-30 | $2,316 |
| 2011-03-31 | $2,018 |
| 2010-12-31 | $1,929 |
| 2010-09-30 | $1,968 |
| 2010-06-30 | $1,985 |
| 2010-03-31 | $1,884 |
| 2009-12-31 | $1,862 |
| 2009-09-30 | $1,948 |
| 2009-06-30 | $1,882 |
| 2009-03-31 | $1,835 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $10.611B | $2.755B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $151.946B | 28.18 |
| CVS Health (CVS) | United States | $90.013B | 11.19 |
| Elevance Health (ELV) | United States | $70.256B | 9.45 |
| Cencora (COR) | United States | $57.138B | 19.03 |
| DiDi Global (DIDIY) | China | $27.156B | 28.85 |
| Labcorp Holdings (LH) | United States | $22.916B | 18.22 |
| Natera (NTRA) | United States | $21.976B | 0.00 |
| BioMerieux (BMXMF) | France | $17.991B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.475B | 0.00 |
| ICON (ICLR) | Ireland | $14.507B | 13.96 |
| Medpace Holdings (MEDP) | United States | $12.983B | 34.36 |
| CochLear (CHEOY) | Australia | $12.561B | 0.00 |
| Solventum (SOLV) | United States | $12.531B | 12.93 |
| Viatris (VTRS) | United States | $12.452B | 4.43 |
| Caris Life Sciences,�Inc (CAI) | United States | $10.386B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $9.321B | 0.00 |
| Avantor (AVTR) | United States | $8.849B | 12.98 |
| Charles River Laboratories (CRL) | United States | $7.799B | 14.80 |
| HealthEquity (HQY) | United States | $7.777B | 34.06 |
| Bausch + Lomb (BLCO) | Canada | $5.172B | 34.79 |
| Sotera Health (SHC) | United States | $4.590B | 25.65 |
| BrightSpring Health Services (BTSG) | United States | $4.106B | 31.32 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| GeneDx Holdings (WGS) | United States | $3.466B | 79.38 |
| Surgery Partners (SGRY) | United States | $2.974B | 37.42 |
| Alignment Healthcare (ALHC) | United States | $2.951B | 0.00 |
| Concentras Parent (CON) | United States | $2.944B | 18.67 |
| Organon (OGN) | United States | $2.407B | 2.62 |
| Premier (PINC) | United States | $2.158B | 20.01 |
| Progyny (PGNY) | United States | $1.955B | 41.35 |
| Ardent Health (ARDT) | United States | $1.849B | 7.14 |
| PACS (PACS) | United States | $1.804B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.623B | 27.47 |
| Pediatrix Medical (MD) | United States | $1.436B | 9.59 |
| Teladoc Health (TDOC) | United States | $1.297B | 0.00 |
| Omada Health (OMDA) | $1.171B | 0.00 | |
| Establishment Labs Holdings (ESTA) | $1.092B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.965B | 0.00 |
| Embecta (EMBC) | United States | $0.798B | 4.67 |
| AMN Healthcare Services Inc (AMN) | United States | $0.769B | 9.51 |
| CareDx (CDNA) | United States | $0.616B | 11.34 |
| Performant Healthcare (PHLT) | United States | $0.601B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.598B | 102.50 |
| Nutex Health (NUTX) | United States | $0.528B | 7.99 |
| Agilon Health (AGL) | United States | $0.518B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.477B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.475B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.466B | 7.00 |
| SBC Medicals (SBC) | United States | $0.424B | 9.30 |
| Enhabit (EHAB) | United States | $0.409B | 26.87 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.392B | 0.00 |
| So-Young (SY) | China | $0.376B | 0.00 |
| Oncology Institute (TOI) | United States | $0.341B | 0.00 |
| LifeMD (LFMD) | United States | $0.290B | 0.00 |
| Beauty Health (SKIN) | United States | $0.274B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.189B | 0.00 |
| DocGo (DCGO) | United States | $0.156B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.124B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.085B | 0.00 |
| KindlyMD (NAKA) | United States | $0.080B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| Biodesix (BDSX) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.050B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.040B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.035B | 0.00 |
| ModivCare (MODV) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.022B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.011B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |